Authors: Terwogt, JMM van Tellingen, O Panday, VRN Huizing, MT Schellens, JHM Huinink, WWT Boschma, MUS Giaccone, G Veenhof, CHN Beijnen, JH

Citation: Jmm. Terwogt et al., Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol (R))and carboplatin in non-small cell lung cancer patients, ANTI-CANC D, 11(9), 2000, pp. 687-694

Authors: Rosing, H Lustig, V van Warmerdam, LJC Huizing, MT Huinink, WWT Schellens, JHM Rodenhuis, S Bult, A Beijnen, JH

Citation: H. Rosing et al., Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusion, CANC CHEMOT, 45(3), 2000, pp. 213-218

Authors: Panday, VRN van Warmerdam, LJC Huizing, MT Rodenhuis, S Schellens, JHM Beijnen, JH

Citation: Vrn. Panday et al., A single 24-hour plasma sample does not predict the carboplatin AUC from carboplatin-paclitaxel combinations or from a high-dose carboplatin-thiotepa-cyclophosphamide regimen, CANC CHEMOT, 43(5), 1999, pp. 435-438

Authors: Panday, VRN van Warmerdam, LJC Huizing, MT Huinink, WWT Schellens, JHM Beijnen, JH

Citation: Vrn. Panday et al., A limited-sampling model for the pharmacokinetics of carboplatin administered in combination with paclitaxel, J CANC RES, 125(11), 1999, pp. 615-620

Authors: van Tellingen, O Huizing, MT Panday, VRN Schellens, JHM Nooijen, WJ Beijnen, JH

Citation: O. Van Tellingen et al., Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel inpatients, BR J CANC, 81(2), 1999, pp. 330-335